|
|
Clinical effect of Oxytocin combined with Misoprostol in preventing postpartum hemorrhage |
LI Shu |
Department of Obstetrics,Baise People′s Hospital in Guangxi Zhuang Autonomous Region,Guangxi Baise 533000,China |
|
|
Abstract Objective To investigate the clinical effect of Oxytocin combined with Misoprostol in preventing postpartum hemorrhage.Methods A total of 120 cases of term vaginal delivery in our hospital were randomly divided into two groups from October 2016 to October 2017,60 cases in each group.The control group was given intramuscular injection of Oxytocin 10 U and intravenous drip of 10 U after delivery,the obseruation group on the basis of the control group,Misoprostol 400 μg plug anus was administered,compared the two groups with the rate of postpartum hemorrhage,the amount of postpartum hemorrhage,the time of the third stage of labor,the changes of blood pressure and heart rate before and after administration.Results The postpartum haemorrhage rate was 1.67%,significantly lower than 15.00%in the control group,significantly less than the control group with 2 h and 24 h,and the differences were statistically significant(P<0.05).The third stage of the observation group was significantly shorter than the control group,and the difference was statistically significant(P<0.05).In the observation group,the systolic blood pressure,diastolic blood pressure and heart rate were significantly decreased compared with the control group,and the differences were statistically significant(P<0.05).There was no significant difference between the two groups in the incidence of nausea,vomiting,cold war,facial flushing,and elevated blood pressure (P>0.05).Conclusion The clinical effect of Oxytocin combined with Misoprostol on the prevention of postpartum hemorrhage is remarkable.It can effectively shorten the third stage of labor,reduce the amount of postpartum hemorrhage,reduce the rate of postpartum hemorrhage,stabilize hemodynamics,and the adverse reaction is slight,which has positive clinical significance.
|
|
|
|
|
[1] |
刘亚静,邬玺钻,李红云,等.缩宫素联合米索前列醇预防产后出血的临床效果观察[J].中国生化药物杂,2016,36(3):37-39.
|
[2] |
俞春蕾.缩宫素联合米索前列醇预防产后出血40例的疗效及临床评价[J].中国药业,2013,22(10):60-61.
|
[3] |
杨继,张慧,高坚容,等.米索前列醇不同给药方式联合缩宫素预防产后出血的临床研究[J].疑难病杂志,2011,10(12):906-908.
|
[4] |
宋婷婷,代秀云,冷海娜.缩宫素联合米索前列醇预防产后出血 30 例临床观察[J].中国当代医药,2011,18(5):53-54.
|
[5] |
杨英.缩宫素联合米索前列醇预防产后出血疗效观察[J].中国实用医刊,2015,42(18):104-105.
|
[6] |
肖金仙.缩宫素联合米索前列醇预防产后出血的临床疗效评价[J].世界临床医学,2015,9(10):144.
|
[7] |
郭玉莲.缩宫素联合米索前列醇预防产后出血的效果观察[J].实用妇科内分泌杂志,2016,3(14):148-149.
|
[8] |
王俊敏.缩宫素联合米索前列醇预防产后出血的疗效观察及护理体会[J].海峡药学,2017,29(9):210-211.
|
[9] |
范明林.缩宫素联合米索前列醇预防产后出血的效果分析[J].海峡药学,2015,27(9):184-185.
|
[10] |
唐海燕,王炎.米索前列醇联合缩宫素预防产后出血的疗效分析[J].中国现代医学杂志,2015,25(1):96-97.
|
[11] |
李辉霞.缩宫素联合米索前列醇在预防产后出血中的临床分析[J].医学理论与实践,2016,29(8):1075-1076.
|
[12] |
张焕敏.缩宫素联合米索前列醇预防产后出血临床效果观察[J].河南外科学杂志,2016,22(6):120-121.
|
[13] |
赵晓颖.缩宫素联合米索前列醇治疗产后出血50例的临床效果分析[J].中国妇幼保健,2014,29(5):807-808.
|
[14] |
杨菊花,潘建萍.米索前列醇联合缩宫素预防产后出血的临床观察[J].现代中西医结合杂志,2011,20(14):1728-1729.
|
[15] |
巩学业,张文娟,齐丽丽.产时应用葡萄糖酸钙联合缩宫素、米索前列醇预防高危产妇产后出血的临床研究(附358 例)[J].现代妇产科进展,2013,22(8):662-663.
|
|
|
|